Versuchen GOLD - Frei
Intas Pharma bags another overseas co
Mint Kolkata
|January 08, 2025
Gujarat-based drug-maker Intas Pharmaceuticals Ltd, which counts private equity firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.
Intas Pharma has agreed to buy Udenyca brand through its US specialty division, Accord BioPharma, for up to $558.4 million (nearly ₹4,800 crore), according to a press release.
Udenyca is the brand name for medication pegfilgrastim-cbqv, a bone marrow stimulant used to treat low white blood-cell counts in patients who take cancer medications.
Diese Geschichte stammt aus der January 08, 2025-Ausgabe von Mint Kolkata.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Kolkata
Mint Kolkata
Arsenal's time might be this season: Michael Owen
The former England and Liverpool player on how the game has changed, Premier League predictions, and the Ballon d'Or
5 mins
October 11, 2025
Mint Kolkata
UPI AutoPay’s endless woes forcing an industry rethink
55-90% of automated payments on UPI AutoPay didn’t go through in Aug, NPCI data shows
2 mins
October 11, 2025
Mint Kolkata
Prosus buys 10% stake in Ixigo parent for ₹1,295 cr
Travel tech platform Ixigo has sold a 10% stake in the company to Dutch investor Prosus for ₹1,295 crore, which it plans to use primarily for investing in artificial intelligence, expanding its hotel business, and acquisitions.
1 min
October 11, 2025
Mint Kolkata
Norms for hazardous chemicals tightened
The government has overhauled more than four-decade-old safety codes that govern the production, handling, and storage of hazardous chemicals, as it seeks to bolster industrial safety and prevent chemical-related mishaps in India.
1 min
October 11, 2025
Mint Kolkata
Silver to stay hot as supply thins amid buyer frenzy
Demand for silver has soared on the back of rising industrial use and investor frenzy, but supply remains constrained.
1 min
October 11, 2025
Mint Kolkata
CaratLane is reshaping the jewellery world
CaratLane has become a household name in fine jewellery. Its recently launched CaratLane Gulnaara, a 73-faceted solitaire crafted for exceptional brilliance is a cut above the rest.
2 mins
October 11, 2025
Mint Kolkata
Investors aren't too excited about TCS's biggest bet
“We are on a journey to become the world’s largest artificial intelligence (AI)-led technology services company,” said Tata Consultancy Services (TCS) Ltd’s chief executive K. Krithivasan in prepared remarks on Thursday after announcing it will spend over $6 billion in about six years to set up data centres.
2 mins
October 11, 2025
Mint Kolkata
Science at the political table
'The Man who Fed India' is a diligent record of India's most impactful agriculture scientist, M.S. Swaminathan
5 mins
October 11, 2025
Mint Kolkata
Inside Mumbai's first crying club
The club seeks to create a safe space where adults can experience the catharsis of weeping with company
4 mins
October 11, 2025
Mint Kolkata
Silver to stay hot as supply thins amid buying frenzy
New mines can’t help, either, Exploring and developing new mines typically takes several years.
1 mins
October 11, 2025
Listen
Translate
Change font size